Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients-Reference-Cited by-同舟云学术

Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients

Published:2017-10 Issue:10 Volume:23 Page:1701-1713
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ivaturi Vijay,Dvorak Christopher C.,Chan Danna^ORCID,Liu Tao^ORCID,Cowan Morton J.^ORCID,Wahlstrom Justin,Stricherz Melisa,Jennissen Cathryn,Orchard Paul J.,Tolar Jakub,Pai Sung-Yun,Huang Liusheng,Aweeka Francesca,Long-Boyle Janel

Funder

Thrasher Research Fund and the National Center for Advancing Translational Sciences

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts;Dow;Cancer Res,1980

2. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase;Brockman;Cancer Res,1980

3. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib);Ritzel;J Biol Chem,2001

4. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia;Molina-Arcas;Blood,2003

5. Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations;Mackey;Blood,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation;Blood Neoplasia;2024-09

3. Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation;Transplantation and Cellular Therapy;2024-05

4. Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies;Pediatric Blood & Cancer;2024-04-12

5. Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity;Transplantation and Cellular Therapy;2024-01